Acetylcholinesterase reactivators are crucial antidotes for the treatment of organophosphate intoxication. Standard in vitro test was chosen using a rat brain homogenate as the source of AChE. Screening of reactivation potency was performed with two concentration of reactivator (1000 µM and 10 µM). Results were compared to established reactivators pralidoxime, methoxime, HI-6, trimedoxime and obidoxime. More than 30 novel reactivators performed equal or better reactivation ability of POX-inhibited AChE compared to currently used reactivators. The structure-activity relationship for reactivators of paraoxon-inhibited AChE was developed.
Introduction
Acetylcholinesterase (AChE 3.1.1.7) belongs to the family of serine hydrolases. It plays a crucial role in the organism. 1 AChE terminates a nervous transmission via degrading a neurotransmitter acetylcholine within the synaptic cleft. 2 Cavity of the enzyme is located in 20 Å (20 nm) deep gorge with active (A) site and peripheral (P) site. 3, 4 A-site contains amino-acids residues of catalytic triad (S203, E334 and H447). 5, 6 P-site plays important role in allosteric modulation of the enzyme activity, it contains residues of Tyr72, Tyr124, Trp286, Tyr341 and Asp74. 5 Organophosphorus compounds (OPCs) are able to inhibit AChE irreversibly. 7 Many organophosphorus AChE inhibitors were synthesized and widely used as pesticides (e.g. parathion, paraoxon, chlorpyrifos, and diazinon) 8, 9 or industrial compounds (e.g. plasticizers and flame retardants). Some of them were developed for military purposes and they are known as nerve agents 10 (e.g. sarin, soman, tabun, and VX). Some OPCs are shown in Figure 1 . OPCs irreversibly inhibit AChE that cannot fulfil its physiological role. Intoxication is manifested by bronchial hypersecretion, salivation, muscle spasms and fasciculation leading to paralysis, depression of breathing centre followed by death. 11, 12 Moreover, inhibited enzyme undergoes a process called "aging". 13 During this process, OPC-AChE complex is dealkylated. None of currently known reactivators is able to restore the AChE function after aging process. 14 Standard treatment of OPC intoxication consists of AChE reactivators, anticholinergic drug (e.g. atropine) and anticonvulsive (e.g. diazepam). 15 AChE reactivators are able to counteract consequences of OPC intoxication and they are an essential part of the standard treatment. 16 Reactivators are monoquaternary or bisquaternary pyridinium salts, which bear an oxime (hydroxy- iminomethyl) group in the molecule. 17, 18 Dissociated oximate anion is able to attack to the covalent bond in the AChE-OPC complex and restores the enzyme function. 19 The pralidoxime (1, 2-hydroxyiminomethyl-1-methylpyridinium chloride), HI-6 (2, 1-(2-hydroxyiminomethylpyridinium)-3-(4-carbamoylpyridinium)-2-oxapropane dichloride) obidoxime (3, 1,3-bis(4-hydroxyiminomethylpyridinium)-2-oxapropane dichloride) are commercially available oxime reactivators 20 ( Figure 2 ). Atropine is used for binding to muscarinic acetylcholine receptors (AChR) with consequent neuronal transduction, therefore prevents from hyperstimulation with ACh and subsequent cholinergic crisis. 21 Diazepam is used for anticonvulsive treatment.
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OP pesticides are easily available and used globally. Moreover, at least 200 000 people annually die of OP pesticide selfpoisoning. 8, 22 Since there is a wide variety of OPCs, none of currently used compounds is able to fairly reactivate AChE inhibited by various pesticides. 23 Additionally, commercial AChE reactivators were originally designed against nerve agents. Hence, new reactivators of OP pesticides are currently requested. 24 In this study, paraoxon was chosen as model OPC for our in vitro screening. Though paraoxon is prohibited OP compound for several decades for its increased toxicity in human, its thioanalogue parathion may still be in use. Parathion is easily bioactivated via CYP-450 to paraoxon.
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Results and Discussion
The previously known compounds (1-7) and over 50 new reactivators (8-63) were assayed for their reactivation ability using rat brain homogenate inhibited by paraoxon. The reactivation results are listed in Table 1-9 .
A reactivation in vitro should exceed 10% to suggest a promising compound warranting further testing. 17, 26 Apparently, not all of the tested compounds were able to fulfil this requirement. Moreover, maximal attainable plasma concentration of reactivator is 100 µM. 27 Consequently, reactivation ability at 10 µM is more relevant concerning further testing and plausible use. Reactivation potency of oximes is better for POX-inhibited AChE comparing to nerve agents, because they undergo slower or no "aging" process. 28 The best reactivation results among standard compounds were obtained for compounds 2, 4, 6 and 7 with concentration 12, 14, 15, 25, 27, 33, 44, 56, 62) . Hence, some structural features were found more beneficial for reactivation of POX-inhibited AChE. In addition, interesting phenomenon was observed, where some compounds showed higher reactivation ability for lower concentration of the reactivator (e. g. 11-12, 14-15, 20-22,  28-29, 32-36, 58, 61-63) . This was probably caused by coincident reactivation and inhibition of the enzyme by reactivator itself as was described earlier. 24 Structural requirements for oxime reactivators were previously described. 19, 29, 30 Some authors used molecular modelling to predict the most effective structure of oxime reactivators, too. 4, 13 The main structural features that influence the reactivation ability are the oxime functional group (its position and amount), number of quaternary nitrogen, varying functional group on non-oxime heteroaromatic ring and the connecting linker (its length and structure) for bisquarternary reactivators. 24, 31 Oxime functional group is essential for reactivation process. For POX-inhibited AChE, at least one oxime group in position four (30) seemed to be beneficial, when compared to related compounds with the oxime in position two (17, 28) or three (18, 29) , especially for 10 µM. Compounds with oxime group in position 3 were much less effective (26 compared to 25 and 27) that was formerly explained by increased pKa of 3-positioned oxime. 17 Furthermore, the reactivation results showed that one oxime group was essential and introduction of second oxime didn't lead to significant increase of reactivation ability (25-30 compared to 56-58).
Differently, the non-oxime functional group may extend the hydrophilic/hydrophobic interactions within the enzyme active sites. 32 From this point of view, the best results were obtained for the isoquinolinium-monooxime reactivator (62; Table 9 ). In this Additionally, compounds with two quaternary pyridinium rings had better reactivation ability compared to monoquaternary reactivators (1, 53-54 compared to 5, 12, 15, 30, 44, 56,  62) . 5, 33 This fact arises from cation-π interactions in the enzyme active sites. Besides this, monoquaternary reactivators significantly improved penetration through BBB compared to bisquaternary compounds, where small and only mono-charged molecules are more valuable. 34, 35 Regarding the connecting linker, an optimal length of the aliphatic linker for POX-inhibited AChE ranges from 3 to 4 methylene units (5, 6, 20-21) as was formerly reported. 19 This structural requirement may be described by spatial distance of two pyridinium moieties that are responsible for crucial cation-π interactions within the AChE active sites and thus higher affinity towards AChE. Among the reactivators with propane linker, the best results were obtained with standard reactivator 5 and 6 and with new reactivators 19-21 for concentration 1000 µM. Same reactivators performed best results for concentration 10 µM with exception of compound 19. Reactivators with (E)-but-2-ene linker showed promising reactivation potency mostly for oximes 25, 30, 38, 44, 56 and 62 for both concentrations. In the group of (Z)-but-2-ene linked reactivators, the best results were obtained for oximes 31 and 33 for concentration 1000 µM and 33 and 35 for 10 µM concentration. (E)-But-2-ene linked compounds resulted as more valuable when compared to (Z)-but-2-ene linked reactivators (56 and 58 to 33-34) . 31, 36 The reactivation ability of the xylene linked compounds was influenced by higher linker rigidity, where xylene linker is spatially plain structure with limited possibilities of free rotation in comparison to aliphatic linkers (e.g. propane). Thus, the only bonds accessible for free rotation in xylene compounds are methylene junctions. These cause the non-coplanar formation of each pyridinium ring versus the xylene ring. Subsequently, the spatial orientation of xylene molecule is shifted, when compared to compound with aliphatic linker. In addition, better results (namely at 10 µM) for xylene reactivators were obtained for compounds with spatially more opened molecules with m-or p-xylene linker (11, 12, 14 and 15). 37 The explanation of these results consist in entering the narrow AChE active gorge (about 5 Å), where o-xylene linked molecules are too bulky for going inside and consequently for successful reactivation. Generally, reactivators with double bond or xylene presented better reactivation ability compared to compounds with aliphatic linkers (7 compared to 27, 7 compared to 12 and 15). These differences were plausibly caused by the presence of the π-electrons in the connection chain and subsequent interactions with aromatic residues (His, Phe, Trp, Tyr) from AChE active sites.
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Conclusions 56 new potential AChE reactivators were tested in vitro and compared to the commercial compounds on the model of paraoxon-inhibited rat brain AChE. Structure-activity relationship was studied within this series compounds. More than 30 tested reactivators showed promising results at 10 µM that is attainable concentration after in vivo administration. The best reactivation results were obtained for bisquarternary molecules with at least one oxime group in position 4 and with connecting linker ranging from 3 to 4 C-C bonds.
Material and Methods
All chemicals were purchased from Fluka or Sigma-Aldrich and used without further purification. Commercial and novel reactivators were synthesized in the Department of Toxicology (Faculty of Military Health Sciences, University of Defence). Their purity was verified by NMR and HPLC-MS methods. 10% rat brain homogenate was used as a source of AChE.
In vitro testing of reactivators was formerly described in detail. 17 This method was chosen instead of Ellman´s method to prevent oximolysis at higher oxime concentrations. Briefly, the 10% rat brain homogenate in distilled water was used as a source of AChE. The brain homogenate (0.5 mL) was mixed with of 1 mM isopropanol solution paraoxon (20 µL; O,O-diethyl-O-(4-nitrophenyl)phosphate, analytical standard 99.2% from SigmaAldrich) and distilled water (0.5 mL). The mixture was incubated at 25 o C for 30 min and 95% inhibition of AChE was achieved. The mixture was filled in assay vessel to the volume 23 mL with distilled water and sodium chloride (3 M, 2.5 mL) was added. Finally, acetylcholine iodide (0.02 M, 2 mL; substrate for enzymatic reaction) was added. The enzyme activity (analyzed by potentiometric titration of decomposed acetylcholine iodide) was measured at pH 7.6 and 25 o C using an autotitrator RTS 822 (Radiometer, Denmark).
The same procedure was repeated with inhibited homogenate (0.8 mL) further subjected to 10 min incubation with an aqueous solution of reactivator (0.2 ml of 1 mM or 10 µM), which replaced 0.2 mL of water. All measurements were done in triplicate. Activities of intact AChE (a0), inhibited AChE (ai) and reactivated AChE (ar) were deduced from the consumption of NaOH solution (0.01 M) in time. The percentage of reactivation (%) was calculated from the measured data according to the formula: 
